BACKGROUND: Familial dilated cardiomyopathy (DCM) is typically a monogenic disorder with dominant inheritance. Although over 40 genes have been linked to DCM, more than half of the patients undergoing comprehensive genetic testing are left without molecular diagnosis. Recently, biallelic protein-truncating variants (PTVs) in the nebulin-related anchoring protein gene (NRAP) were identified in a few patients with sporadic DCM. METHODS AND RESULTS: We determined the frequency of rare NRAP variants in a cohort of DCM patients and control patients to further evaluate role of this gene in cardiomyopathies. A retrospective analysis of our internal variant database consisting of 31,639 individuals who underwent genetic testing (either panel or direct exome sequencing) was performed. The DCM group included 577 patients with either a confirmed or suspected DCM diagnosis. A control cohort of 31,062 individuals, including 25,912 individuals with non-cardiac (control group) and 5,150 with non-DCM cardiac indications (Non-DCM cardiac group). Biallelic (n = 6) or two (n = 5) NRAP variants (two PTVs or PTV+missense) were identified in 11 unrelated probands with DCM (1.9%) but none of the controls. None of the 11 probands had an alternative molecular diagnosis. Family member testing supports co-segregation. Biallelic or potentially biallelic NRAP variants were enriched in DCM vs. controls (OR 1052, p<0.0001). Based on the frequency of NRAP PTVs in the gnomAD reference population, and predicting full penetrance, biallelic NRAP variants could explain 0.25%-2.46% of all DCM cases. CONCLUSION: Loss-of-function in NRAP is a cause for autosomal recessive dilated cardiomyopathy, supporting its inclusion in comprehensive genetic testing.
BACKGROUND:Familial dilated cardiomyopathy (DCM) is typically a monogenic disorder with dominant inheritance. Although over 40 genes have been linked to DCM, more than half of the patients undergoing comprehensive genetic testing are left without molecular diagnosis. Recently, biallelic protein-truncating variants (PTVs) in the nebulin-related anchoring protein gene (NRAP) were identified in a few patients with sporadic DCM. METHODS AND RESULTS: We determined the frequency of rare NRAP variants in a cohort of DCM patients and control patients to further evaluate role of this gene in cardiomyopathies. A retrospective analysis of our internal variant database consisting of 31,639 individuals who underwent genetic testing (either panel or direct exome sequencing) was performed. The DCM group included 577 patients with either a confirmed or suspected DCM diagnosis. A control cohort of 31,062 individuals, including 25,912 individuals with non-cardiac (control group) and 5,150 with non-DCM cardiac indications (Non-DCM cardiac group). Biallelic (n = 6) or two (n = 5) NRAP variants (two PTVs or PTV+missense) were identified in 11 unrelated probands with DCM (1.9%) but none of the controls. None of the 11 probands had an alternative molecular diagnosis. Family member testing supports co-segregation. Biallelic or potentially biallelic NRAP variants were enriched in DCM vs. controls (OR 1052, p<0.0001). Based on the frequency of NRAP PTVs in the gnomAD reference population, and predicting full penetrance, biallelic NRAP variants could explain 0.25%-2.46% of all DCM cases. CONCLUSION: Loss-of-function in NRAP is a cause for autosomal recessive dilated cardiomyopathy, supporting its inclusion in comprehensive genetic testing.
Authors: Christine A Henderson; Christopher G Gomez; Stefanie M Novak; Lei Mi-Mi; Carol C Gregorio Journal: Compr Physiol Date: 2017-06-18 Impact factor: 9.090
Authors: Rowida Almomani; Judith M A Verhagen; Johanna C Herkert; Erwin Brosens; Karin Y van Spaendonck-Zwarts; Angeliki Asimaki; Paul A van der Zwaag; Ingrid M E Frohn-Mulder; Aida M Bertoli-Avella; Ludolf G Boven; Marjon A van Slegtenhorst; Jasper J van der Smagt; Wilfred F J van IJcken; Bert Timmer; Margriet van Stuijvenberg; Rob M Verdijk; Jeffrey E Saffitz; Frederik A du Plessis; Michelle Michels; Robert M W Hofstra; Richard J Sinke; J Peter van Tintelen; Marja W Wessels; Jan D H Jongbloed; Ingrid M B H van de Laar Journal: J Am Coll Cardiol Date: 2016-02-09 Impact factor: 24.094
Authors: Roddy Walsh; Kate L Thomson; James S Ware; Birgit H Funke; Jessica Woodley; Karen J McGuire; Francesco Mazzarotto; Edward Blair; Anneke Seller; Jenny C Taylor; Eric V Minikel; Daniel G MacArthur; Martin Farrall; Stuart A Cook; Hugh Watkins Journal: Genet Med Date: 2016-08-17 Impact factor: 8.822
Authors: Grażyna T Truszkowska; Zofia T Bilińska; Angelika Muchowicz; Agnieszka Pollak; Anna Biernacka; Katarzyna Kozar-Kamińska; Piotr Stawiński; Piotr Gasperowicz; Joanna Kosińska; Tomasz Zieliński; Rafał Płoski Journal: Sci Rep Date: 2017-06-13 Impact factor: 4.379
Authors: Antonio Rueda Martin; Eleanor Williams; Rebecca E Foulger; Sarah Leigh; Louise C Daugherty; Olivia Niblock; Ivone U S Leong; Katherine R Smith; Oleg Gerasimenko; Eik Haraldsdottir; Ellen Thomas; Richard H Scott; Emma Baple; Arianna Tucci; Helen Brittain; Anna de Burca; Kristina Ibañez; Dalia Kasperaviciute; Damian Smedley; Mark Caulfield; Augusto Rendon; Ellen M McDonagh Journal: Nat Genet Date: 2019-11 Impact factor: 38.330
Authors: Robert Lesurf; Abdelrahman Said; Oyediran Akinrinade; Jeroen Breckpot; Kathleen Delfosse; Ting Liu; Roderick Yao; Gabrielle Persad; Fintan McKenna; Ramil R Noche; Winona Oliveros; Kaia Mattioli; Shreya Shah; Anastasia Miron; Qian Yang; Guoliang Meng; Michelle Chan Seng Yue; Wilson W L Sung; Bhooma Thiruvahindrapuram; Jane Lougheed; Erwin Oechslin; Tapas Mondal; Lynn Bergin; John Smythe; Shashank Jayappa; Vinay J Rao; Jayaprakash Shenthar; Perundurai S Dhandapany; Christopher Semsarian; Robert G Weintraub; Richard D Bagnall; Jodie Ingles; Marta Melé; Philipp G Maass; James Ellis; Stephen W Scherer; Seema Mital Journal: NPJ Genom Med Date: 2022-03-14 Impact factor: 8.617